Teva to sell generic version of Novo Nordisk’s diabetic drug in US
Israel’s Teva Pharmaceuticals will start selling a generic version of Novo Nordisk’s type 2 diabetic drug Victoza in the US market.
Drugs
Health
Pharma
Drugs
Health
Pharma
Novo Nordisk to set up $4.1 billion injectables facility in US’s North Carolina
Novo Nordisk, a Danish pharmaceutical multinational, will invest $4.1 billion to build a new factory in the US to make obesity and chronic.
Drugs
Health
Pharma
FDA gives nod to Bristol Myer’s colorectal cancer therapy
The US Food and Drug Administration has greenlighted Bristol Myers Squibb’s combination therapy to treat metastatic colorectal cancer in patients with a mutated.
Drugs
Health
Pharma
Eli Lilly’s Zepbound resolves sleep apnea in more than half of trial patients
Tirzepatide, an obesity drug of Eli Lilly and Company, has helped resolve moderate-to-severe obstructive sleep apnea in 52.% of adult patients in two.
Climate
Health
Pharma
A third of world’s largest marine protected areas exploited: Study
A third of the world’s largest marine protected areas (MPAs) are indulging in destructive activities such as industrial fishing, a global study reveals.
Drugs
Health
Pharma
WHO issues medical alert on falsified weight-loss, diabetic drugs
The World Health Organization has issued a medical product alert on falsified semaglutides, an active ingredient in Ozempic, a diabetic drug made by.
Climate
Health
Pharma
Heatwaves sweep across globe, Paris Olympic athletes may face the heat
Heatwaves are continuing to sweep across the world with “numerous record-breaking” high temperatures possible in the US, according to meteorological departments and weather.
Drugs
Health
Pharma
Roche to pay $42 million to Ascidian to make RNA exon editing drugs
Ascidian Therapeutics, a US-based biotechnology company announced a $42 million research pact with Swiss multinational Roche AG for developing gene editing therapies.
Drugs
Health
Pharma
AstraZeneca’s trial breast cancer drug fails to meet primary goals
AstraZeneca’s end-stage experimental trial to treat a certain type of breast cancer failed to meet its dual primary goals, according to a statement.
Drugs
Health
Pharma
Takeda’s trials for epilepsy treatment fail to meet primary seizure goals
Takeda Pharmaceutical Company’s two trials for treating epilepsy did not meet its primary goals of seizure frequency, the Japanese company announced.